Minyoung Lee

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Mild Cognitive Impairment

Diabetic Nephropathy

Randomized Controlled Trial

Combination Therapy

Top Venues

Diabetes, obesity & metabolism

Yonsei medical journal

Journal of clinical medicine

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Hae Kyung Kim, Geert Jan Biessels, Min Heui Yu, Namki Hong, Yong-Ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Eun Jig Lee, Minyoung Lee
SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes. Neurology 103 (8) (2024)
Jaehyun Bae, Young-Eun Kim, Minyoung Lee, Eun Young Lee, Byung-Wan Lee, Bong Soo Cha, Eun Seok Kang
Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes. Yonsei medical journal 63 (6) (2022)
Minyoung Lee, Woo-Je Lee, Jae Hyeon Kim, Byung-Wan Lee
Effectiveness and safety of teneligliptin added to patients with type 2 diabetes inadequately controlled by oral triple combination therapy: A multicentre, randomized, double-blind, and placebo-controlled study. Diabetes, obesity & metabolism 24 (6) (2022)
Minyoung Lee, Kwang Joon Kim, Tae-Ha Chung, Jaehyun Bae, Eun Young Lee, Byung-Wan Lee, Bong Soo Cha, Mijin Yun, Eun Seok Kang
Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes. Diabetes, obesity & metabolism 23 (4) (2021)
Hyung Sik Kim, Min Young Park, Nam Joo Yun, Hye Sun Go, Mi Young Kim, Je-Kyung Seong, Minyoung Lee, Eun Seok Kang, Jaewang Ghim, Sung Ho Ryu, Brian A Zabel, Ara Koh, Yoe-Sik Bae
Targeting PLD2 in adipocytes augments adaptive thermogenesis by improving mitochondrial quality and quantity in mice. The Journal of experimental medicine 219 (2) (2021)
Minyoung Lee, Ho Seon Park, Min Yeong Choi, Hak Zoo Kim, Sung Jin Moon, Ji Yoon Ha, ARim Choi, Young Woo Park, Jong Suk Park, Eui-Cheol Shin, Chul Woo Ahn, Shinae Kang
Significance of Soluble CD93 in Type 2 Diabetes as a Biomarker for Diabetic Nephropathy: Integrated Results from Human and Rodent Studies. Journal of clinical medicine 9 (5) (2020)
Jaehyun Bae, Ji Hye Huh, Minyoung Lee, Eun Young Lee, Byung-Wan Lee
Glycaemic control with add-on thiazolidinedione or a sodium-glucose co-transporter-2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24-week, randomized controlled trial. Diabetes, obesity & metabolism 23 (2) (2020)
Minyoung Lee, Jiyu Sun, Minkyung Han, Yongin Cho, Ji-Yeon Lee, Chung-Mo Nam, Eun Seok Kang
Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors. Diabetes care 42 (11) (2019)
Hannah Seok, Minyoung Lee, Eugene Shin, Mi Ra Yun, Eun Young Lee, Jae Hoon Moon, Eosu Kim, Phil Hyu Lee, Byung-Wan Lee, Eun Seok Kang, Hyun Chul Lee, Bong Soo Cha
Low-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus. Scientific reports 9 (1) (2019)
Jin Hee Kim, Minyoung Lee, Soo Hyun Kim, So Ra Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Jin Won Cho, Eun Young Lee
Sodium-glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter-organ crosstalk. Diabetes, obesity & metabolism 21 (4) (2018)